(He recommends you take a half position only because these Top Picks are trading at multiples that are higher than average, but are still attractive as long-term investments.) Radiation therapy for brain cancer. A Swedish firm where the suffering is on the hardware side, but they also supply all the software that goes with it. Trading at a PEG ratio of about 1. They are #1 in their industry in that category. Do a lot of business in the Middle East and Asia and demand there is picking up as middle incomes begin to grow.
Electa AB is a OTC stock, trading under the symbol EKTAB-SS on the (). It is usually referred to as or EKTAB-SS
In the last year, there was no coverage of Electa AB published on Stockchase.
Electa AB was recommended as a Top Pick by on . Read the latest stock experts ratings for Electa AB.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year 0 stock analysts on Stockchase covered Electa AB. The stock is worth watching.
On , Electa AB (EKTAB-SS) stock closed at a price of $.
(BNN had the date as Nov 28/13, but I show Nov 8/13.) (A Top Pick Nov 8/13. Down 3.75%.) Healthcare. The Swedish krona has done well so there is some currency growth. This is another situation where at the back end of the year, if their earnings come back up, they have the ability to see their earnings pop. Dividend is growing at roughly 20%-25% a year. Still thinks they have some terrific growth to come.